Owkin Stock
HealthTechLooking to sell Owkin stock or options?
Owkin is a developer of machine learning tools created to enhance biological and medical research. The company's tool merges genomics, biomedical images, and clinical data to uncover biomarkers and mechanisms associated with diseases and outcomes of treatments, aiming to develop models that offer maximum interpretability. This empowers researchers in universities, hospitals, and pharmaceutical companies to comprehend why patient responses to drugs vary, streamline the drug development process, and identify the most effective drug for each patient, thereby improving treatment results.
Third Kind Venture Capital, Key Ventures, Otium Capital, Jean-Paul Clozel, F-Prime Capital, NJF Capital, Jorg Mohaupt, Brent Hoberman, Bpifrance, Sanofi, Google for Startups, Eight Roads, Cathay Capital Private Equity, Groupe MACSF, Frst Capital, Joël Besse, Cathay Innovation, Plug and Play Tech Center, GV, Mubadala Capital, Bristol-Myers Squibb.